Search

The objective was to assess adherence to voluntary agreements for sodium reduction firmed between the food industries and the Ministry of Health in Brazil and to compare their targets with the limit proposed in the Pan American Health Organization (PAHO) nutritional profile model. We used data from 1.553 foods from 32 categories included in the agreements and sold in the largest Brazilian supermarket chains in 2017. The frequency of products with sodium equal or below the cut-offs proposed by the voluntary agreements and by PAHO was calculated. Classification concordance according to the two was evaluated with Cohen's kappa coefficient (k). Our results showed that 77.7% of products were adequate according to the voluntary agreements, and only 35.9% of them, according to the PAHO model. We identified a weak degree of concordance between both criteria in classifying a product as adequate about sodium content (k = 0.199). In conclusion, the voluntary agreements for sodium reduction are limited in their scope and rigor. The adoption of measures oriented for all products, with more restrictive and mandatory targets, should be considered in the country.

Objectives: This study aimed to perform a cost-effectiveness analysis (CEA) of the molecular diagnostic method (MM) associated with conventional diagnostic method (CM) compared with the CM alone, for the detection of resistant profile in bacteremia, from the perspective of the Brazilian Public Health System, in intensive care units setting., Methods: The clinical parameters regarding methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Gram-negative bacteria (CRGNB), and vancomycin-resistant Enterococcus spp. (VRE) infections were collected from searches on PubMed, Scopus, and SciELO, using specific keywords. Data on direct medical costs to treat these infections were collected according to Brazilian Public Health System perspective from Brazilian databases, in tables of 2018 to 2019. CEA was performed after building a dynamic model, which was calibrated and validated according to international recommendations. The incremental cost-effectiveness ratio of the MM + CM compared with the CM was calculated using the outcomes "avoided death" and "avoided resistant infections." One-way sensitivity analyses were performed., Results: This CEA demonstrated that the MM + CM was dominant in all scenarios. Estimates showed that for MRSA, CRGNB, and VRE infections, every avoided death would lead to savings of Brazilian real (R$) 4.9 million ($937 301), R$2.2 million ($419 899), and R$1.3 million ($248 919), respectively. The same infections assessed by avoided resistant infections savings were projected to be R$24 964 ($4686), R$40 260 ($7558), and R$23 867 ($4480)., Conclusions: MM leads to cost reduction and increased benefits, optimizing the use of financial resources on the health system in the intensive care unit setting, in bacteremia caused by MRSA, CRGNB, and VRE., (Copyright © 2021 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. Published by Elsevier Inc. All rights reserved.)